Detection of atrial high-rate events by continuous Home Monitoring: Clinical significance in the heart failurecardiac resynchronization therapy population

Europace

Volumn 14, Issue 2, 2012, Pages 230-237

  Shanmugam, Nesan ^a   Boerdlein, Annegret ^b   Proff, Jochen ^b   Ong, Peter ^a   Valencia, Oswaldo ^a   Maier, Sebastian K G ^c   Bauer, Wolfgang R ^c   Paul, Vince ^d   Sack, Stefan ^e  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b Biotronik SE and Co KG   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d ROYAL PERTH HOSPITAL   (Australia)

^e Klinikum Schwabing   (Germany)

Author keywords

Anticoagulation; Atrial fibrillation; Cardiac resynchronization therapy; Heart failure; Home monitoring; Thromboembolism

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART ATRIUM DISORDER; HEART DEATH; HEART DISEASE; HEART EJECTION FRACTION; HEART FAILURE; HIGH RISK PATIENT; HOME MONITORING; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOEMBOLISM;

AGED; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; COHORT STUDIES; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART FAILURE; HOME CARE SERVICES; HUMANS; INTERNATIONALITY; MALE; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84856293368     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur293     Document Type: Article

References (25)

1. National Collaborating Centre for Chronic conditions. Atrial fibrillation: national clinical guideline for the management in primary and secondary care. 2006. Royal College of Physicians. Ref Type: Report.
2. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-33. (Pubitemid 35417773)
3. Schaer BA, Zellweger MJ, Cron TA, Kaiser CA, Osswald S. Value of routine Holter monitoring for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemic events. Stroke 2004; 35: e68-70.
4. Israel CW, Gronefeld G, Ehrlich JR, Li YG, Hohnloser SH. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol 2004; 43: 47-52. (Pubitemid 38045914)
5. Varma N, Epstein AE, Irimpen A, Schweikert R, Love C, TRUST Investigators. Efficacy and safety of automatic remote monitoring for implantable cardioverterdefibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 2010; 122: 325-32.
6. Purerfellner H, Gillis AM, Holbrook R, Hettrick DA. Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing Clin Electrophysiol 2004; 27: 983-92. (Pubitemid 38970216)
7. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-70. (Pubitemid 32537350)
8. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-429.
9. Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2009; 2: 474-80.
10. Caldwell JC, Contractor H, Petkar S, Ali R, Clarke B, Garratt CJ et al. Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy. Europace 2009; 11: 1295-300.
11. Borleffs CJ, Ypenburg C, van Bommel RJ, Delgado V, van Erven L, Schalij MJ et al. Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy. Heart Rhythm 2009; 6: 305-10.
12. Santini M, Gasparini M, Landolina M, Lunati M, Proclemer A, Padeletti L et al. Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. J Am Coll Cardiol 2011; 57: 167-72.
13. Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 2003; 107: 1614-9. (Pubitemid 36397330)
14. Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G et al. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005; 46: 1913-20. (Pubitemid 41579816)
15. Healey JS, Connolly SJ, Gold MR, Capucci A, Israel C, van Gelder IC et al. The relationship between atrial high-rate episodes and stroke: the Asymptomatic Stroke and Atrial Fibrillation Evaluation in Pacemaker Patients (ASSERT) trial. Circulation 2010; 122: 2220-1. 23-11-2010. Abstract 21838.
16. Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Zolezzi F et al. Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009; 20: 241-8.
17. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke prevention in atrial fibrillation investigators. J Am Coll Cardiol 2000; 35: 183-7. (Pubitemid 30061278)
18. Sparks PB, Jayaprakash S, Mond HG, Vohra JK, Grigg LE, Kalman JM. Left atrial mechanical function after brief duration atrial fibrillation. J Am Coll Cardiol 1999; 33: 342-9. (Pubitemid 29234195)
19. Daoud EG, Glotzer TV, Wyse DG, Ezekowitz MD, Hilker C, Koehler J et al. TRENDS Investigators, The temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm 2011; 8: 1416-23.
20. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946-52. (Pubitemid 28446646)
21. Ip J, Waldo AL, Lip GY, Rothwell PM, Martin DT, Bersohn MM et al. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study. Am Heart J 2009; 158: 364-70.
22. Lazarus A. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. Pacing Clin Electrophysiol 2007; 30(Suppl 1): S2-12. (Pubitemid 46121800)
23. Pollak WM, Simmons JD, Interian A Jr., Atapattu SA, Castellanos A, Myerburg RJ et al. Clinical utility of intraatrial pacemaker stored electrograms to diagnose atrial fibrillation and flutter. Pacing Clin Electrophysiol 2001; 24(4 Pt 1): 424-9. (Pubitemid 32374862)
24. Hoppe UC, Casares JM, Eiskjaer H, Hagemann A, Cleland JG, Freemantle N et al. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure. Circulation 2006; 114: 18-25. (Pubitemid 44305270)
25. Saxon LA. Does cardiac resynchronization therapy reduce the incidence of atrial fibrillation, and does atrial fibrillation compromise the cardiac resynchronization therapy effect? Heart Rhythm 2007; 4(3 Suppl): S31-3.